Results · Apr-Jun 2026
Metropolis Healthcare Q1 FY27 results
Very strongVery strong: sales up 15% or more & profit up 25% or more on the same quarter last year, with a wider operating margin.
Sales grew 17% to ₹450 crore from ₹386 crore in Apr-Jun 2025.
Operating profit grew 24% to ₹111 crore, an operating margin of 24.7% (up 1.4 points from a year ago).
Net profit grew 26% to ₹56.9 crore from ₹45.2 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +6%, net profit +12%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 450.2 | 386.1 | +17% |
| Operating profit (EBITDA) | 111.2 | 89.8 | +24% |
| Operating margin | 24.7% | 23.2% | +1.4 pts |
| Net profit | 56.9 | 45.2 | +26% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.